How useful is serology for COVID-19?
Open Access
- 27 October 2020
- journal article
- editorial
- Published by Elsevier BV in International Journal of Infectious Diseases
- Vol. 102, 170-171
- https://doi.org/10.1016/j.ijid.2020.10.058
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Evaluating the serological status of COVID-19 patients using an indirect immunofluorescent assay, FranceEuropean Journal of Clinical Microbiology & Infectious Diseases, 2020
- COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series studyInternational Journal of Antimicrobial Agents, 2020
- Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19Annals of Internal Medicine, 2020
- Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date reviewInternational Journal of Infectious Diseases, 2020
- Children and Adolescents With SARS-CoV-2 InfectionThe Pediatric Infectious Disease Journal, 2020
- Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adultsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2020
- Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological studyThe Lancet, 2020
- Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysisTravel Medicine and Infectious Disease, 2020